Asked by: Layla Moran (Liberal Democrat - Oxford West and Abingdon)
Question to the Department for Science, Innovation & Technology:
To ask the Secretary of State for Science, Innovation and Technology, what steps she is taking to ensure social media companies protect consumers from illegal content advertising weight loss jabs.
Answered by Kanishka Narayan - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
The Online Safety Act gives online platforms duties to tackle illegal content and activity on their services. This includes content advertising illegal sales of drugs. Ofcom is the regulator for this regime, and it sets out steps that providers can take to comply with their duties. Ofcom has strong powers to enforce against platforms that fail to fulfil their duties to protect users from illegal content.
The government is clear that people should only purchase medicines and medical products through legitimate, regulated channels. Anyone with weight or health concerns should consult their GP or a qualified healthcare professional who can provide safe, appropriate treatment options.
Asked by: Layla Moran (Liberal Democrat - Oxford West and Abingdon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help raise awareness among young people of the risks of sudden cardiac death in (a) grass roots sports clubs and (b) higher education settings.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
To reduce the risks of sudden cardiac death, NHS England has published a national service specification for inherited cardiac conditions that covers patients who often present as young adults with previously undiagnosed cardiac disease or families requiring follow-up due to a death from this cause. This describes the service model and guidance that should be followed to support diagnosis and treatment of patients or family members. It also includes the requirement for specialised inherited cardiac conditions services to investigate suspected cases.
Asked by: Layla Moran (Liberal Democrat - Oxford West and Abingdon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to gather additional data on the (a) effectiveness and (b) safety of the Respiratory Syncytial Virus vaccination in people that are over 80.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The UK Health Security Agency (UKHSA) undertakes monitoring and evaluation of immunisation programmes, including the effectiveness of vaccines. The Medicines and Healthcare Products Regulatory Agency (MHRA) monitors vaccine safety. The UKHSA and the MHRA are in regular contact with manufacturers over new and emerging data from their products.
Evidence of effectiveness and safety in relevant age groups in the United States of America, which implemented older adult vaccination a season ahead of the United Kingdom, was used to inform the Joint Committee on Vaccination and Immunisation’s (JCVIs) considerations on extending the UK programme to adults aged 80 years old and older. The JCVI’s meeting minutes and statement of 16 July 2025 advising an extension to the UK respiratory syncytial virus (RSV) programme are available at the following link:
https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation
The JCVI keeps the RSV programme under regular review. Evidence on the safety and effectiveness of RSV vaccines in all age groups in all countries where data has been made available is used to inform JCVI advice.